Search research articles
Contact Us
Filters
Showing results (151-160 of 177) with videos related to
Page
of 18
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
April 3, 2007
The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer
Blaise Lippa, Goss S Kauffman, Joel Arcari, et al.
The Journal of Biological Chemistry
|
June 15, 2000
The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane
B D Moyer, M Duhaime, C Shaw, et al.
Plos One
|
September 5, 2014
Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain
Jacinthe Gingras, Sarah Smith, David J Matson, et al.
Molecular Pain
|
December 1, 2016
Selective antagonism of TRPA1 produces limited efficacy in models of inflammatory- and neuropathic-induced mechanical hypersensitivity in rats
Sonya G Lehto, Andy D Weyer, Beth D Youngblood, et al.
Cancer Research
|
August 9, 2003
The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells
E Gabriella Barbacci, Leslie R Pustilnik, Ann Marie K Rossi, et al.
The Journal of Biological Chemistry
|
March 11, 2008
Small molecule activator of the human epithelial sodium channel
Min Lu, Fernando Echeverri, Dalia Kalabat, et al.
Plos One
|
May 4, 2018
Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V
Bryan D Moyer, Justin K Murray, Joseph Ligutti, et al.
Cancer Research
|
November 14, 1997
Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase
J D Moyer, E G Barbacci, K K Iwata, et al.
Medchemcomm
|
August 16, 2018
Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent Na<sub>V</sub>1.7 inhibitors
Brian A Sparling, S Yi, J Able, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 8, 2017
Discovery of a biarylamide series of potent, state-dependent Na<sub>V</sub>1.7 inhibitors
Laurie B Schenkel, Erin F DiMauro, Hanh N Nguyen, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 177) with videos related to
Sort By:
Page
of 18
Bioorganic & Medicinal Chemistry Letters
|
April 3, 2007
The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer
Blaise Lippa, Goss S Kauffman, Joel Arcari, et al.
The Journal of Biological Chemistry
|
June 15, 2000
The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane
B D Moyer, M Duhaime, C Shaw, et al.
Plos One
|
September 5, 2014
Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain
Jacinthe Gingras, Sarah Smith, David J Matson, et al.
Molecular Pain
|
December 1, 2016
Selective antagonism of TRPA1 produces limited efficacy in models of inflammatory- and neuropathic-induced mechanical hypersensitivity in rats
Sonya G Lehto, Andy D Weyer, Beth D Youngblood, et al.
Cancer Research
|
August 9, 2003
The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells
E Gabriella Barbacci, Leslie R Pustilnik, Ann Marie K Rossi, et al.
The Journal of Biological Chemistry
|
March 11, 2008
Small molecule activator of the human epithelial sodium channel
Min Lu, Fernando Echeverri, Dalia Kalabat, et al.
Plos One
|
May 4, 2018
Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V
Bryan D Moyer, Justin K Murray, Joseph Ligutti, et al.
Cancer Research
|
November 14, 1997
Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase
J D Moyer, E G Barbacci, K K Iwata, et al.
Medchemcomm
|
August 16, 2018
Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent Na<sub>V</sub>1.7 inhibitors
Brian A Sparling, S Yi, J Able, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 8, 2017
Discovery of a biarylamide series of potent, state-dependent Na<sub>V</sub>1.7 inhibitors
Laurie B Schenkel, Erin F DiMauro, Hanh N Nguyen, et al.
Page
of 18